Public COA audit

CJC-1295_Ipamorelin · CJC-1295 Ipamorelin

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
93%
Panels
3/7
Purity (printed)
99.9%

Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), and 2 soft concerns. To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-CJIP20-2603-1
Identity method
FTIR (USP <197A>)
Sample date
2026-04-02
Issue date
2026-04-05

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    FTIR sample spectrum confirms the presence of CJC1295_Ipamorelin with addition of excipient(s)/fillers

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.9%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    19.1 EU/vial (limit: 40 EU/vial)

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity

    99.9% purity by HPLC (USP <621>) meets specification of ≥98%. This is normal for research-grade peptides.

  • FTIR identity confirmed

    FTIR spectrum confirms presence of CJC-1295_Ipamorelin with excipients/fillers. Includes visual FTIR spectrum on page 2.

  • Lot number present

    Lot CR-CJIP20-2603-1 clearly stated on all pages

  • Testing dates documented

    Sample tested 2026-04-02, purity/identity report issued 2026-04-05, endotoxin report issued 2026-04-10. All dates are on or before 2026-09-05 (today).

  • Lab information complete

    BTLabs, West Palm Beach FL. Contact info and website provided. Two scientists signed both reports.

  • Endotoxin testing included

    Separate endotoxin report (page 3) shows gel clot LAL test result of 19.1 EU/vial, passing the 40 EU/vial limit. This is a split report for the same lot.

  • Potency below specification

    HPLC potency assay shows 49.6-79.3% of labeled 20mg content (specification: 90-110%). This indicates underfilling or lower-than-claimed peptide content, though purity of the peptide present is high.

  • Limited panel scope

    No heavy metals, microbial contamination, sterility, or residual solvent/water testing documented. Page 1 explicitly states the report does not provide information on particulate matter, microbial contamination beyond endotoxins.

  • Professional presentation

    Multi-page report with FTIR and HPLC chromatograms, QR code, signatures, triplicate measurements. Consistent formatting across both reports.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.